1 – 10 of 380
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
SPARC : The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
- Contribution to journal › Article
-
Mark
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer : Findings from the International, Multicenter PROMISE Registry
- Contribution to journal › Article
-
Mark
Prognostic value of tumour volume based on [18F]PSMA-1007 PET/CT in prostate cancer
- Contribution to journal › Article
-
Mark
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study
- Contribution to journal › Article
- 2025
-
Mark
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk
- Contribution to journal › Debate/Note/Editorial
-
Mark
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer : An International, Paired, Noninferiority, Confirmatory Observer Study
- Contribution to journal › Article
-
Mark
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research
- Contribution to journal › Article
-
Mark
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer
- Contribution to journal › Article
-
Mark
pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy
- Contribution to journal › Article
-
Mark
Semi-standardized evaluation of extraprostatic extension and seminal vesicle invasion with [18F]PSMA-1007 PET/CT : a comparison to MRI using histopathology as reference
- Contribution to journal › Article
